Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001050 · ClinicalTrials.gov registry record
Study of Women Who Have AIDS
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 1,250
- Enrollment target
NCT00001050: Clinical Trial study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00001050 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001050 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 1,250 participants
- Enrollment target
Study Summary
To study the effect of pregnancy, age, drug use, and coinfections on HIV progression rate. To document the prevalence, incidence, characteristics, and course of HIV infection and anogenital intraepithelial neoplasia among HIV-positive and HIV-negative women. To study the effect of HIV disease on gynecologic health including infections and reproductive function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
Why NCT00001050 stopped before completion
NCT00001050 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001050 about?
NCT00001050 is a clinical study titled "Study of Women Who Have AIDS". To study the effect of pregnancy, age, drug use, and coinfections on HIV progression rate. To document the prevalence, incidence, characteristics, and course of HIV infection and anogenital intraepithelial neoplasia among HIV-positive and HIV-negative women. To study the effect of HIV disease on gyn...
What is the current status of trial NCT00001050?
This trial is currently terminated. The enrollment target is 1,250 participants.
Who is sponsoring clinical trial NCT00001050?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies